Coya Therapeutics (COYA) Return on Sales [ROS] (2023 - 2026)
Coya Therapeutics' Return on Sales [ROS] was -2891.13% in Q2 2026, up 1029.34 percentage points from -3920.47% a year earlier and up 151.00 percentage points from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Return on Sales [ROS] (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Coya Therapeutics' Return on Sales [ROS] was -288.70% through Jun 30, 2026, up 5053.59 percentage points year-over-year; for FY2025, it came in at -283.87%, up 201.49 percentage points from FY2024.
- In earlier years, Return on Sales [ROS] was -485.35% in FY2024 (-353.68 pp) and -131.67% in FY2023.
- Quarterly Return on Sales [ROS] has moved between -209031.51% (Q4 2024) and 30.24% (Q4 2023) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in four of the last seven quarters, with an average year-over-year change of -235.41 percentage points.
- Per Business Quant data, COYA's Return on Sales [ROS] in the three quarters before Q2 2026 was -3042.13% (Q1 2026), -152.30% (Q4 2025) and -68.26% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,126.20 Bn | 1,094.78 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 633.36 Bn | 553.22 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.51 Bn | 477.62 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 357.58 Bn | 311.96 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 289.65 Bn | 253.64 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 264.97 Bn | 238.66 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.69 Bn | 193.09 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.48 Bn | 168.68 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 28.37% |
| 10 | Coya Therapeutics | 94.12 Mn | -74.76 Mn | - | -2,891.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,891.13% |
| Mar 31, 2026 | -3,042.13% |
| Dec 31, 2025 | -152.30% |
| Sep 30, 2025 | -68.26% |
| Jun 30, 2025 | -3,920.47% |
| Mar 31, 2025 | -2,976.89% |
| Dec 31, 2024 | -209,031.51% |
| Sep 30, 2024 | -118.84% |
| Jun 30, 2024 | -94.48% |
| Mar 31, 2024 | -4,322.84% |
| Dec 31, 2023 | 30.24% |
API Access
Coya Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();